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Evolution of Porcine Reproductive and Respiratory Syndrome Virus
during Sequential Passages in Pigs
Abstract
Porcine reproductive and respiratory syndrome (PRRS) viruses are recognized as possessing a high degree of
genetic and antigenic variability. Viral diversity has led to questions regarding the association of virus
mutation and persistent infection in the host and has raised concerns vis-à-vis protective immunity, the ability
of diagnostic assays to detect novel variants, and the possible emergence of virulent strains. The purpose of
this study was to describe ongoing changes in PRRS virus during replication in pigs under experimental
conditions. Animals were inoculated with a plaque-cloned virus derived from VR-2332, the North American
PRRS virus prototype. Three independent lines of in vivo replication were maintained for 367 days by pig-to-
pig passage of virus at 60-day intervals. A total of 315 plaque-cloned viruses were recovered from 21 pigs over
the 367-day observation period and compared to the original plaque-cloned virus by virus neutralization
assay, monoclonal antibody analysis, and sequencing of open reading frames (ORFs) 1b (replicase), 5 (major
envelope protein), and 7 (nucleocapsid) of the genome. Variants were detected by day 7 postinoculation, and
multiple variants were present concurrently in every pig sampled over the observation period. Sequence
analysis showed ORFs 1b and 7 to be highly conserved. In contrast, sequencing of ORF 5 disclosed 48
nucleotide variants which corresponded to 22 amino acid variants. Although no epitopic changes were
detected under the conditions of this experiment, PRRS virus was shown to evolve continuously in infected
pigs, with different genes of the viral genome undergoing various degrees of change.
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Porcine reproductive and respiratory syndrome (PRRS) viruses are recognized as possessing a high degree
of genetic and antigenic variability. Viral diversity has led to questions regarding the association of virus
mutation and persistent infection in the host and has raised concerns vis-à-vis protective immunity, the ability
of diagnostic assays to detect novel variants, and the possible emergence of virulent strains. The purpose of this
study was to describe ongoing changes in PRRS virus during replication in pigs under experimental conditions.
Animals were inoculated with a plaque-cloned virus derived from VR-2332, the North American PRRS virus
prototype. Three independent lines of in vivo replication were maintained for 367 days by pig-to-pig passage
of virus at 60-day intervals. A total of 315 plaque-cloned viruses were recovered from 21 pigs over the 367-day
observation period and compared to the original plaque-cloned virus by virus neutralization assay, monoclonal
antibody analysis, and sequencing of open reading frames (ORFs) 1b (replicase), 5 (major envelope protein),
and 7 (nucleocapsid) of the genome. Variants were detected by day 7 postinoculation, and multiple variants
were present concurrently in every pig sampled over the observation period. Sequence analysis showed ORFs
1b and 7 to be highly conserved. In contrast, sequencing of ORF 5 disclosed 48 nucleotide variants which
corresponded to 22 amino acid variants. Although no epitopic changes were detected under the conditions of
this experiment, PRRS virus was shown to evolve continuously in infected pigs, with different genes of the viral
genome undergoing various degrees of change.
Porcine reproductive and respiratory syndrome (PRRS) first
appeared as catastrophic, uncontrollable, clinical outbreaks in
swine herds in North America, Europe, and Asia in the late
1980s and early 1990s (10, 13, 26, 57). The etiology of PRRS
was established in 1991 when a previously unrecognized virus
was identified as the causal agent (57).
PRRS virus (PRRSV) is a member of the family Arteriviri-
dae, along with equine arteritis virus, lactate dehydrogenase-
elevating virus of mice, and simian hemorrhagic fever virus (9,
48). PRRSV is enveloped and has a polyadenylated, single-
stranded, nonsegmented, positive-sense RNA genome 15 kb in
size (7, 14, 34, 35). The genome consists of eight open reading
frames (ORFs) that are expressed through the production of a
nested set of subgenomic 3-coterminal mRNAs (14, 34, 35).
ORF 1, which comprises two-thirds of the genome, encodes
the viral RNA-dependent RNA polymerase (14, 37). ORFs 2
to 7 are postulated to encode structural proteins, but only three
proteins have been consistently identified in virions and/or
lysates of virus-infected cells. These three are the 15-kDa nu-
cleocapsid (N), 19-kDa matrix (M), and 25-kDa envelope (E)
glycoproteins that are encoded by ORFs 7, 6, and 5, respec-
tively (41, 42). Proteins encoded by ORFs 2 to 4 are designated
GP2, GP3, and GP4, where GP indicates glycoprotein and the
number designates the ORF from which it is derived (36, 56).
PRRSV infection is prevalent in swine-producing regions
throughout the world. Infection with PRRSV produces viremia
with subsequent dissemination to and viral replication in mul-
tiple organs (50, 52). The virus replicates predominantly in
cells of the monocyte/macrophage lineage (47, 50, 52, 57).
Clinically, infection may range from totally inapparent to caus-
ing severe disease. Generally, clinical signs involve reproduc-
tive disorders in pregnant animals and/or respiratory disease in
pigs of all ages (11, 20, 21, 23, 47, 51, 63). Reproductive disease
in pregnant animals is manifested as late-term abortions or
premature farrowings. Affected litters have higher proportions
of stillbirths and piglets born weak and increased preweaning
mortality (11, 23, 63).
PRRSV produces a persistent infection despite an active
immune response (1, 6, 20, 27, 60). The PRRSV carrier state
was first recognized in an experiment that documented the
transmission of virus from animals infected 99 days earlier to
commingled sentinel pigs (66). Subsequently, Wills et al. (60)
reported the isolation of virus at up to 157 days postinoculation
(p.i.). Persistence is an important epidemiological feature be-
cause it provides a ready means for PRRSV to perpetuate
itself through a cycle of transmission from carrier to suscepti-
ble animals. As a consequence, the elimination of PRRSV
from herds is difficult, and cyclic bouts of PRRSV-associated
health problems are commonplace.
The mechanism(s) by which the virus persists in the host is
not known, but PRRSV isolates are characterized by a high
degree of genetic and antigenic variability. Persistence in the
host and viral diversity could be two manifestations of the same
function. Genetic analyses have shown the existence of at least
two major virus genotypes, the European and the North Amer-
ican, with extensive genetic variability both within and between
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these genotypes. Nelsen et al. (40) found important differences
between the prototypic North American (VR-2332) and Eu-
ropean (Lelystad) viruses in the 5 leader sequence and parts
of ORF 1a. Marked differences were also found between Eu-
ropean and North American isolates in some structural genes
(24, 39). ORF 7 is highly conserved among North American
isolates, with 95 to 100% amino acid homology, but a compar-
ison of North American viruses and the Lelystad virus revealed
only 57 to 59% amino acid homology (32, 39). ORF 6 is the
most conserved gene among North American isolates, with up
to 100% amino acid identity, and is the most conserved gene
between North American and European isolates, with 70 to
81% identity (24, 33, 39). The amino acid sequence homology
for ORF 5 varies from 88 to 97% among North American
isolates and from 51 to 59% when North American viruses are
compared to the Lelystad virus (4, 24, 31, 39). A comparison of
the Lelystad virus with isolate ATCC VR-2332, the North
American prototype virus, revealed amino acid identities of 63,
58, and 68% for ORFs 2, 3, and 4, respectively (39). Similar
results were reported when the Lelystad virus was compared
with U.S. isolate VR-2385 (38).
Genetic diversity is mirrored in antigenic diversity among
PRRSV isolates. Antigenic variation was initially demon-
strated in a comparison of European and North American
isolates. Using an immunoperoxidase monolayer assay, Wens-
voort et al. (58) evaluated the reactivity of porcine polyclonal
antibodies raised against either the Lelystad virus or North
American isolate ATCC VR-2332 with PRRSV isolates from
around the world. The investigators were able to differentiate
European from North American isolates on the basis of dif-
ferences in immunoperoxidase monolayer assay antibody ti-
ters. That is, significantly higher antibody titers were obtained
in the homologous assay system. Later studies found even
greater antigenic diversity among PRRSV isolates than initially
suspected (5, 15, 17, 28, 64). Yoon et al. (64) examined 22
PRRSV isolates recovered from samples collected between
1989 and 1993 in eight different U.S. states. With a panel of
five monoclonal antibodies (MAbs) specific for the N protein,
the 22 virus isolates fell into one of three groups based on their
reactivity patterns. Yang et al. (61) expanded this study to 70
North American isolates from samples collected between 1989
and 1995 and a panel of 23 MAbs against the N protein. Their
results showed five antigenic groups, with the European Lelys-
tad virus representing an antigenic group distinct from any of
the North American groups identified. Furthermore, with an-
tibodies against discontinuous epitopes of the N and M pro-
teins and continuous epitopes of the E protein and GP3, the 65
North American isolates in the first and second antigenic
groups (I15 and II15) were further subdivided into nine and
four antigenic subgroups, respectively (62).
That field isolates of PRRSV show a remarkable degree of
genetic and antigenic variability has become abundantly evi-
dent. Understanding the source and degree of virus diversity is
important because of its potential impact on viral virulence,
persistence in the host, protective immunity, and even on the
ability to diagnose the infection. The assumption is that these
changes occur during the course of in vivo replication in swine
and arise, in large part, because of errors that occur during
RNA replication. However, the degree and rate of mutation of
PRRSV in infected pigs over time are not known. To address
this question, we examined the genetic and antigenic changes
that occurred in a well-characterized PRRSV isolate during
the course of multiple pig passages over a period of 367 days.
MATERIALS AND METHODS
Experimental design. The objective of the study was to characterize PRRSV
mutations during prolonged in vivo replication. The experiment began by inoc-
ulating pigs free of PRRSV and virus-specific antibody with a highly homologous
inoculum of a well-characterized PRRSV. Three independent lines (A, B, and C)
of in vivo virus replication were established and monitored over seven animal
passages (passage 1 [P1] to P7). Pigs in a fourth line (D) served both as mock-
infected negative controls and as environmental sentinels (Fig. 1). Virus was
periodically recovered from individual pigs in lines A, B, and C over a period of
367 days and compared genetically and antigenically to the original PRRSV.
In P1, three 14- to 21-day-old PRRSV-free pigs (1A, 1B, and 1C) were
inoculated intranasally (1 ml per naris) and intramuscularly (8 ml per pig) with
a 3-plaque-cloned PRRSV designated VR-2332-CC-01 (see below) at a titer of
106 50% tissue culture infective doses (TCID50) per ml. A fourth pig (1D) was
inoculated with cell culture medium. Animals were housed in HEPA-filtered
isolation units (Barrier Systems, Inc., Tom River, N.J.) to prevent exposure to
extraneous viruses. For 60 days p.i., pigs were observed daily and serum samples
were collected periodically for virological and serological assays. At 60 days p.i.,
the animals were euthanatized and whole blood in EDTA, samples of tissues
(tonsils, lungs, spleen, and tracheobronchial and medial iliac lymph nodes), and
bronchoalveolar lavage fluid were collected. For each subsequent passage after
P1, four PRRSV-free pigs were randomly assigned to the two groups and inoc-
ulated as described above, except that tissue homogenate filtrate prepared from
the postmortem samples collected from the pig in the previous passage was used
in place of the cell culture-derived PRRSV inoculum. The use of tissue homog-
enate made it possible to expose animals directly to pig-adapted PRRSV and
avoid any selective pressures arising from isolation and replication of the virus in
cell cultures.
Viruses, cells, and media. The North American prototype PRRSV ATCC
VR-2332 (American Type Culture Collection, Manassas, Va.) was used in the
study. VR-2332 was selected because the complete genomic sequence has been
published (GenBank accession no. PRU87392) (40) and the epitopic profile has
been described (61, 62). The virus was propagated on MARC-145 cells, a clone
of the African monkey kidney cell line MA-104 that is considered highly per-
missive to PRRSV (25). The cells were cultured and maintained in culture
FIG. 1. Experimental design. The diagram illustrates three inde-
pendent lines (A, B, and C) and seven pig passages (P1 to P7) of
PRRSV. Pigs 1A, 1B, and 1C were inoculated with plaque-cloned
PRRSV. Pigs in P2 to P7 were inoculated with tissue filtrates from the
corresponding pig in the previous passage.
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medium composed of Dulbecco’s modified Eagle’s medium (DMEM; Sigma
Chemical Co., St Louis, Mo.) supplemented with 10% fetal bovine serum (Hy-
Clone Laboratories, Inc., Logan, Utah), 50 g of gentamicin (Sigma)/ml, and
0.25 g of amphotericin B (Fungizone; Sigma)/ml.
To produce a highly homologous challenge virus, the stock virus was subjected
to three rounds of plaquing on MARC-145 cells. Briefly, the stock virus was
10-fold serially diluted (i.e., 101 to 106) with culture medium. Two milliliters
of each dilution was inoculated into each well of a six-well plate (Corning Inc.,
Corning, N.Y.) containing 24-h-old confluent MARC-145 cells. Inoculated cells
were incubated for 2 h at 37°C in a humidified 5% CO2 incubator. At the end of
the incubation period, the inocula were discarded and the cells were rinsed twice
with culture medium and then covered with 4 ml of overlay medium composed
of 0.2% agarose (FMC Bioproducts, Rockland, Maine), 10% fetal bovine serum,
50 g of gentamicin/ml, and 0.25 g of amphotericin B/ml in DMEM. The cells
were incubated for 3 to 7 days at 37°C in a humidified 5% CO2 atmosphere.
During the incubation period, well-demarcated plaques were selected, sus-
pended in 2 ml of culture medium, and then propagated once on MARC-145
cells. This process was repeated three times. Following the third round of pla-
quing, one virus clone, designated VR-2332-CC-01 (hereafter referred to as
CC-01), was selected and propagated once on MARC-145 cells to obtain an
amount sufficient for inoculating the pigs in P1. Surplus CC-01 was divided into
aliquots and stored at 80°C for future use.
The same procedure was used to recover plaque-cloned virus isolates from
pigs. That is, 15 plaque-cloned virus isolates were recovered from each of the
three pigs in each of the seven passages by directly diluting the serum samples
collected on day 7 p.i. with the procedure described above. The use of viremic
serum samples made it possible to recover viruses directly from pigs and elimi-
nated the requirement for virus isolation in cell cultures prior to plaque cloning.
This process also served to reduce the selection effect of cell culturing on the
recovery of plaque-cloned viruses. It was not expected that sequencing 15 clones
from each pig and passage would identify all the unique nucleotide and amino
acid sequences present in each pig. A rare sequence was unlikely to be included
in the sample. However, if the true prevalence of a sequence exceeded 18%, then
it was presumed with 95% or higher probability that we would be able to observe
at least one clone of that sequence in our sample. Selected plaque-cloned viruses
were propagated once on MARC-145 cells, divided into aliquots, and stored at
80°C until used. Fifteen plaque-cloned viruses were also obtained from the
original virus inoculum to document the genetic and antigenic characteristics of
CC-01, assess the variability of the virus population within the inoculum, and
provide a baseline for comparisons.
Animals and animal care. Throughout the study, animals were housed and
cared for in compliance with the requirements given in Guide for the Care and
Use of Agricultural Animals in Agricultural Research and Teaching (17a).
For the study, crossbred pigs were obtained from a closed specific-pathogen-
free herd known to be free of PRRSV. Pigs were weaned at 10 to 14 days of age,
ear tagged, and randomly assigned to a treatment. Weaned pigs were group
housed in HEPA-filtered isolation units for several days prior to exposure to
virus and then individually housed in the isolation units from the time of expo-
sure until the end of the observation period. The isolation units were equipped
with internal flush mechanisms that allowed for disposal of waste products while
maintaining a biosecure environment. Likewise, a sealed system permitted feed-
ing without jeopardizing biosecurity. Contact with the external environment and
other animals was eliminated to the greatest degree possible. Inoculations and
sample collections were scheduled so that only one pig was removed from its
isolation unit in any 24-h period. Immediately following inoculation or sample
collection, the environment was cleaned and then disinfected with chlorhexidine
diacetate disinfectant (Nolvasan Solution; Fort Dodge Laboratories, Fort
Dodge, Iowa).
Biological samples. Blood samples were collected from all pigs on days 0, 7, 14,
21, 28, 35, and 60 p.i. with a single-use blood collection system (Vacutainer;
Becton Dickinson, Franklin Lakes, N.J.). After 30 min at room temperature, the
serum was harvested by centrifugation of the sample at 1,000  g for 10 min. At
day 60 p.i., pigs were euthanatized and necropsied. Whole blood, tonsils, tra-
cheobronchial and medial iliac lymph nodes, spleen, lungs, and bronchoalveolar
lavage fluid were collected from each animal. Whole blood samples were col-
lected with a single-use blood collection system containing EDTA (Vacutainer)
and processed immediately after sampling to obtain peripheral blood leukocytes
(PBLs) as previously described (43). Briefly, whole blood in EDTA was centri-
fuged at 800 g and 4°C for 30 min. The PBLs at the interface of the plasma and
red blood cells were collected and resuspended in 3 ml of Hanks’ balanced salt
solution (HBSS; Sigma). The cell suspension was then layered over an equal
volume of Histopaque-1077 (Sigma) and centrifuged at 1,200  g and 4°C for 20
min. The PBLs at the interface of the upper medium layer and the lower
erythrocyte layer were collected and then washed twice by resuspension in 10 ml
of HBSS and centrifugation at 200  g for 10 min. All samples were stored at
80°C.
To prepare inocula for P2 through P7, biological samples (tonsils, lymph
nodes, spleen, lungs, PBLs, and lung lavage fluid) were suspended in cold HBSS
at approximately 20% (wt/vol). The pool was homogenized in a Stomacher 80
(Seward, London, United Kingdom) for 2 min and then centrifuged at 4,000 
g for 30 min at 4°C. The supernatant was passed through a 0.2-m-pore-size
nonpyrogenic nitrocellulose membrane filter (Corning) and used to inoculate the
next pig.
ELISA. A commercial enzyme-linked immunosorbent assay (ELISA) kit
(IDEXX Laboratories, Inc., Westbrook, Mass.) for the detection of antibody
specific for PRRSV was used by following the directions supplied by the man-
ufacturer. According to the manufacturer, samples for which the ratio of net
optical density of test sample to net optical density of positive control (S/P) is
0.4 are positive for antibody against PRRSV.
Virus titration. A microtitration infectivity assay was performed to assess the
virus titer of the original inoculum, as well as the levels of PRRSV in serum
samples collected over time from pigs in P1 through P7. Briefly, samples were
10-fold serially diluted (i.e., 100 to 106) in culture medium. One hundred
microliters of each dilution was added to each of 3 wells of a 96-well microti-
tration plate (Corning) containing 24-h-old confluent MARC-145 cell monolay-
ers. Inoculated cells were incubated at 37°C in a humidified 5% CO2 incubator.
Each sample was run in duplicate. The cells were monitored daily for cytopathic
effects (CPE) for up to 7 days. If CPE were not evident, the cells were fixed with
aqueous 80% acetone solution, dried, stained with fluorescein isothiocyanate-
conjugated MAb SDOW17 (Rural Technologies, Brookings, S.Dak.), which is
specific for the N protein of PRRSV, and visualized with fluorescence micros-
copy. The presence of PRRSV was determined based on the observation of
virus-specific CPE and/or fluorescence reaction. Virus titers were determined by
using the method described by Reed and Muench (49) and were expressed as
TCID50 per milliliter.
VN assay. A one-way virus neutralization (VN) assay with constant antibody
and various virus concentrations was performed as described previously (62) to
compare the relative susceptibilities of pig-derived plaque-cloned virus isolates
to the neutralizing activity of serum and to screen for potential escape mutant
viruses. A total of 105 plaque-cloned viruses were examined in the one-way VN
assay, i.e., 15 clones from the CC-01 inoculum, 45 clones from P1 (15 clones from
each of three pigs), and 45 clones from P7 (15 clones from each of three pigs).
The P1 clones represented 7 days and the P7 clones represented 367 days of in
vivo replication.
To perform the assay, virus clones were 10-fold serially diluted in DMEM
supplemented with 50 g of gentamicin/ml and 0.25 g of amphotericin B/ml.
Serum collected from each of three pigs (1A, 1B, and 1C) at the termination of
P1 (day 60 p.i.) served as the source of antibody. The assay was performed in
duplicate for each combination of antibody source and virus clone. Serum sam-
ples were heat inactivated at 56°C for 45 min and then diluted 1:2. Fifty micro-
liters of each diluted virus clone was mixed with an equal volume of diluted
serum. An additional 50 l of each diluted virus clone mixed with an equal
volume of cell culture medium instead of antiserum served as an untreated
control. All mixtures were incubated for 1 h at 37°C, and then 100 l of each
mixture was added to 96-well plates containing 24-h-old confluent MARC-145
cell monolayers in the same manner as that described above for virus titration.
Inoculated cells were incubated for up to 7 days. At the end of the 7-day
incubation period, the virus titer of each clone was calculated for each plaque
clone in the presence and absence of antiserum and was expressed as TCID50 in
log10 units. The relative susceptibility of plaque-cloned viruses was calculated
with the following equation and was expressed as the VN index: [(TCID50
without antiserum TCID50 with antiserum)/TCID50 without antiserum] 100.
MAb analysis. The epitopic profile of each of 150 plaque-cloned viruses, i.e.,
15 clones from the CC-01 inoculum, 45 clones from P1 (day 7 of in vivo repli-
cation), 45 clones from P2 (day 67 of in vivo replication), and 45 clones from P7
(day 367 of in vivo replication) was determined with a panel of MAbs in an
indirect immunofluorescence assay (61). The panel consisted of five MAbs
against the N protein and two against the E protein. The production and char-
acterization of the MAbs have been described elsewhere (61, 62).
To prepare PRRSV-infected cell monolayers, 24-h-old confluent MARC-145
cells in 96-well plates were inoculated with optimally diluted virus. Procedures
for control wells were identical except that the cells were not inoculated with
virus. At 24, 48, or 72 h, plates were fixed by immersion in aqueous 80% acetone
solution for 10 min, air dried, and stored at 20°C until used. MAbs used in the
assay were optimally diluted with 0.01 M phosphate-buffered saline (PBS, pH
7.2). Individual wells received 40 l of each MAb dilution, after which plates
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were incubated at 37°C for 45 min in a humid environment. After the MAb
solution was discarded, plates were washed three times with PBS. To visualize
the presence of antigen-antibody complexes, each well received 40 l of 1:100-
diluted goat anti-mouse immunoglobulin G conjugated to fluorescein isothio-
cyanate (Kirkegaard & Perry Laboratories, Gaithersburg, Md.), after which
plates were incubated for 45 min in a humid environment at 37°C. Plates were
then washed three times with PBS and air dried. The reactivity of each MAb with
each virus clone was evaluated by using fluorescence microscopy.
RT-PCR and sequencing. A total of 150 plaque-cloned viruses were sequenced
for ORFs 1b and 7, i.e., 15 clones from the CC-01 inoculum, 45 clones from P1
(day 7 of in vivo replication), 45 clones from P2 (day 67 of in vivo replication),
and 45 clones from P7 (day 367 of in vivo replication). A total of 330 virus clones
were sequenced for ORF 5, including 15 clones from the CC-01 inoculum and 45
plaque-cloned viruses collected from each of the seven passages (n  315). Fifty
plaque-cloned viruses from the CC-01 inoculum were included in each sequenc-
ing reaction to assess the homogeneity of the inoculum and any random muta-
tion(s) which could be introduced during reverse transcription (RT)-PCRs or
sequencing reactions.
Viral RNA for RT-PCR amplification and sequencing was extracted from each
plaque-cloned virus with a QIAamp viral RNA minikit (Qiagen Inc., Valencia,
Calif.) by following the protocols recommended by the manufacturer. Viral RNA
was collected and stored at 80°C until used.
The RT-PCR of ORF 1b was performed with 5 l of extracted RNA by using
a Qiagen OneStep RT-PCR kit according to the manufacturer’s protocol and
primers 8100 and VRBP2 (Table 1). RT was performed for 30 min at 50°C.
Reverse transcriptase was inactivated and Taq polymerase was activated by
raising the temperature to 95°C for 15 min. PCR amplification was achieved with
35 cycles of annealing at 57°C for 30 s, extension at 72°C for 45 s, and denatur-
ation at 94°C for 45 s. Products were polished by incubation at 72°C for 7 min.
For ORF 5 RT-PCR, 10 l of extracted RNA template was added to a tube
containing 50 l of 2 reaction mixture (0.4 mM each dNTP and 2.4 nM
MgSO4), 2 l of RT-Taq mixture, and 34 l of RNase-free H2O (SuperScript
one-step RT-PCR with Platinum Taq; Life Technologies, Grand Island, N.Y.); 2
l of Prime RNase inhibitor (Brinkmann, Westburg, N.Y.); 1 l (5 pmol) of
primer P5F; and 1 l (5 pmol) of primer P5R (Table 1). The RT-PCR was
performed with a thermocycler (GeneAmp PCR system 2400; PE Biosystems,
Foster City, Calif.) at 50°C for 30 min and 92°C for 2 min; then, 35 cycles of
denaturation at 92°C for 15 s, annealing at 50°C for 30 s, and extension at 72°C
for 30 s followed. After the last cycle, the extension period was maintained at
72°C for another 2 min, and then all final products were stored at 4°C until used.
To confirm the positive reaction, 2 l of the final products was separated by
electrophoresis in a 1% agarose gel (Amresco Inc., Solon, Ohio) containing 0.1%
ethidium bromide in Tris-borate-EDTA buffer. The positive products were vi-
sualized and photographed under UV light, and the remaining products were
stored at 4°C until used.
The ORF 7 RT-PCR procedure was identical to that described above for ORF
5 except for the use of a pair of sense (P7F) and antisense (P7R) primers (Table
1), designed as previously reported (12), and 58°C instead of 50°C for the
annealing process.
In every round of RT-PCR, RNA extracted from reference PRRSV was used
as a positive control and mock-infected cell culture fluid was used as a negative
control. The final RT-PCR products were purified with either QIAquick or
96-well PCR purification kits (Qiagen) by following the procedures recom-
mended by the manufacturer. The final purified product was collected and stored
at 4°C until sequenced.
Sequencing reactions for ORF 1b were carried out at the University of Min-
nesota Advanced Genetic Analysis Center (St. Paul) by using 4 l of purified
PCR product and 3.2 pmol each of primers RESP1BP.1 and VRBP2 (Table 1).
Sequencing of ORF 5 and ORF 7 was performed at the Iowa State University
Nucleic Acid Facility (Ames) by using the appropriate amount of purified PCR
product (30 g/l) and 5 pmol of each primer. Primers P5F, P5R, PS1, and PS1R
were used for ORF 5 and primers P7F and P7R were used for ORF 7 (Table 1).
For all three ORFs, pairs of primers were primed from the positions before and
after the target sequences. However, for ORF 5, PS1 and PS1R were also used
to increase sequence accuracy and were primed from the middle of ORF 5 in
both directions.
Analysis of data. ELISA S/P values were analyzed by fitting a regression model
to longitudinal data (16). An appropriate model for the time course in each pig
was chosen by using plots of the results and observations of antibody responses.
A simple model that fit the data from day 7 through day 60 was ELISA S/P  
  log (day)  ε. Differences among lines and generations were tested sepa-
rately for each parameter of the model.
Viremia data from days 7 to 35 were analyzed by analysis of variance and by
longitudinal regression methods. Data for days 0 and 60 were excluded because
no virus was detected at those times. All analyses were done with the average of
two replicate determinations of log10 TCID50 for each pig and day. The analysis
of variance was done with a split-plot analysis to account for the repeated
measures across days. However, because there was a significant three-way inter-
action among passage, lines (A, B, and C), and day p.i., longitudinal data analysis
(16) was used to find a simpler model for the time course of viremia in each pig.
A quadratic regression equation, log10 TCID50     day  	 day2  ε, was
fit to data from each pig. In the model,  was an intercept that was the same for
all groups,  was the slope of the line, ε was the error associated with each
observation, and 	 was the quadratic coefficient. The day of peak viremia (Dpeak)
was estimated for each pig from the quadratic regression coefficients as follows:
Dpeak  /2	. Differences among lines and generations were tested separately
for each parameter.
Data from the VN assay were summarized by using the mean VN index for
each combination of isolate and P1 antiserum. An escape mutant was considered
to be a virus clone with a significantly smaller mean VN index.
Sequence alignment, comparisons, and phylogenetic analyses were carried out
by using computer software from DNASTAR Inc., Madison, Wis. Nucleotide
sequences of VR-2332 (40) and the RespPRRS vaccine strain (GenBank acces-
sion no. AF159149) (2) were obtained and included in the sequence analyses for
comparative purposes. Like the RespPRRS vaccine strain, CC-01 is derived from
VR-2332. Nucleotide mutation rates and amino acid sequence changes over the
course of the experiment were compared to those of CC-01. The mutation rates
were calculated as the proportion of substitutions and were expressed as mean
percent change separately for ORFs 1b, 5, and 7 per plaque-cloned virus. Phy-
logenetic trees representing amino acid variations in the E protein (ORF 5) and
the polymerase (ORF 1b), GP5, and the N protein combined were computed by
using the Hein method with the PAM250 weight table (22).
RESULTS
Clinical observations, viremia, and antibody responses.
HEPA-filtered housing units, necessary to protect pigs from
exposure to extraneous viruses, barred the investigators from
contact with animals, except as required for sample collection.
For that reason, clinical observations were based on percepti-
TABLE 1. Primers used for PCR and sequencing










a From GenBank accession no. PRU87392 (40).
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ble changes in behavior, rather than direct examination. Fol-
lowing inoculation with cell culture-derived virus or tissue ho-
mogenate filtrates from inoculated animals, all pigs in the
experimental group exhibited mild to moderate lethargy and
anorexia, occasionally with dyspnea, beginning on day 2 and
occasionally lasting up to day 10 p.i. All pigs appeared clinically
normal thereafter. No remarkable or consistent difference in
the severity of disease was observed between passages.
ELISA-detectable antibody responses and PRRS viremia in
successive passages (P2 to P7) showed that inoculation of pigs
with tissue homogenate filtrates resulted in transmission of the
infection. All pigs in lines A, B, and C showed similar humoral
immune responses, as measured by the ELISA (Fig. 2). No
statistically significant differences were found in the ELISA
responses among lines A, B, and C for any sampling time.
All pigs in lines A, B, and C became viremic following
inoculation (Fig. 3). The data for individual pigs were fit to a
quadratic equation, and the day of peak viremia was estimated
for each passage and line (Table 2). Statistical analyses showed
that the responses were not the same among all lines or pas-
sages. Comparisons of the slopes of lines A, B, and C showed
a significant difference in the viremia pattern between lines A
and B (P  0.0057) but no difference between lines A and C (P
 0.19) or lines B and C (P  0.13). Specific comparisons
between passages also showed a highly significant difference (P

 0.0001) between the slope of the line for P1 and the mean
slope for P2 through P7. A higher level of PRRS viremia
quickly developed in pigs that received tissue homogenate
from P1, whereas viremia at a lower level but for a much longer
duration was observed in pigs inoculated with CC-01. This
result suggested an adaptive difference between cell culture-
derived PRRSV and pig-passaged PRRSV.
All pigs in line D, i.e., negative controls and environmental
sentinels, remained free of PRRSV and virus-specific antibody
throughout the experiment. These results provided evidence
that biosecurity procedures effectively prevented the inadver-
tent transmission of PRRSV among pigs.
Genetic characterization of the CC-01 inoculum. Partial
ORF 1b sequences (435 bases), complete ORF 5 nucleotide
sequences (603 bases), and complete ORF 7 nucleotide se-
quences (372 bases) were obtained for the 15 plaque-cloned
viruses derived from the CC-01 inoculum. The ORF 1b, 5, and
7 sequences of all 15 clones were identical during repeated
sequencing attempts. This result demonstrated the homogene-
ity of the original virus population, proved that no random
mutation was introduced during PCR and sequencing, and
provided a baseline for comparing and contrasting virus clones
recovered in later passages.
Relative to VR-2332, the ORF 5 nucleotide sequence of
CC-01 differed at three positions: 38 (G to A), 252 (C to T),
and 451 (A to G). These changes resulted in amino acid sub-
stitutions at two residues: 13 (arginine to glutamine) and 151
(arginine to glycine). Compared to the RespPRRS vaccine
virus, the ORF 5 sequence of CC-01 had one synonymous
nucleotide change at position 252 (C to T). In contrast, the
ORF 1b nucleotide sequence of CC-01 was identical to those
of VR-2332 and the RespPRRS vaccine virus. The ORF 7
nucleotide sequences of VR-2332 and the RespPRRS vaccine
virus were identical, but CC-01 differed in two synonymous
mutations at positions 30 (G to T) and 345 (C to T).
Assessment of genetic changes. (i) Sequence analysis of
PRRSV ORF 5. Complete ORF 5 nucleotide sequences were
obtained for 315 swine-derived virus clones (15 clones per pig,
three pigs per passage, and seven passages). These clones rep-
resented 7, 67, 127, 187, 247, 307, and 367 days of in vivo
FIG. 2. Antibody response to PRRSV infection. Values represent
means and standard deviations of ELISA S/P ratios in line A (F), line
B (Œ), and line C () over all passages (P1 to P7).
FIG. 3. Level and duration of viremia. Values represent means and
standard deviations in pigs (P1) inoculated with cell culture-derived
PRRSV (E) and pigs (P2 to P7) inoculated with pig-passaged virus in
line A (F), line B (Œ), and line C ().
TABLE 2. Estimated day of peak viremia by line and passage
Passage
Day p.i. at which peak viremia occurred in line:
A B C
1 18.8 23.4 20.9
2 4.1 8.7 6.2
3 6.4 10.9 8.5
4 6.9 11.4 9.0
5 4.3 8.9 6.4
6 9.0 13.5 11.1
7 8.2 12.7 10.3
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replication in P1 through P7, respectively. As shown in Table 3,
three or more ORF 5 nucleotide variants (5NVs) were de-
tected in every pig beginning as early as day 7 p.i. Six 5NVs
were recovered from one pig. Among the 315 virus clones, 291
differed from CC-01 in the ORF 5 nucleotide sequence. In fact,
no clone with 100% homology to the CC-01 ORF 5 sequence
was detected after P1. In total, 48 5NVs, each containing from
one to eight nucleotide substitutions, were observed. No nu-
cleotide insertions or deletions were detected.
Nucleotide mutations producing amino acid substitutions
were observed in 289 of the 315 clones (Table 4). The amino
acid sequences of the remaining 26 virus clones were identical
to that of CC-01. No virus clone with the original CC-01 amino
acid sequence was detected after P1. A total of 22 ORF 5
amino acid variants (5AVs) were observed, with as many as
five 5AVs being detected in a single pig.
At both the nucleotide and the amino acid levels, ORF 5
continued to mutate over the course of the 367-day observa-
tion period. The majority of variants were transient, i.e., ap-
peared and then disappeared from later passages. The most
TABLE 3. Chronological appearance of 48 5NVs within three independent lines and over seven pig passages
Genotype
No. of plaque-cloned viruses identical to each genotype within the following passage and linea:
P1 P2 P3 P4 P5 P6 P7
A B C A B C A B C A B C A B C A B C A B C
CC-01b 5 12 7 — — — — — — — — — — — — — — — — — —
5NV-01 7 — 5 10 — 13 — — — — — — — — — — — — — — —
5NV-02 1 — — — — — — — — — — — — — — — — — — — —
5NV-03 1 — 1 — — — — — — — — — — — — — — — — — —
5NV-04 1 — — — — — — — — — — — — — — — — — — — —
5NV-05 — 1 — — — — — — — — — — — — — — — — — — —
5NV-06 — 1 1 — — — — — — — — — — — — — — — — — —
5NV-07 — 1 — — — — — — — — — — — — — — — — — — —
5NV-08 — — 1 — — — — — — — — — — — — — — — — — —
5NV-09 — — — 2 — — — — — — — — — — — — — — — — —
5NV-10 — — — 1 — — — — — — — — — — — — — — — — —
5NV-11 — — — 1 — — — — — — — — — — — — — — — — —
5NV-12 — — — 1 — — — — — — — — — — — — — — — — —
5NV-13 — — — — 9 1 — — — — — — — — — — — — — — —
5NV-14 — — — — 6 — — — — — — — — — — — — — — — —
5NV-15 — — — — — 1 — — — — — — — — — — — — — — —
5NV-16 — — — — — — 14 — — — — — — — — — — — — — —
5NV-17 — — — — — — 1 — — — — — — — — — — — — — —
5NV-18 — — — — — — — 13 — — — — — — — — — — — — —
5NV-19 — — — — — — — 1 — — — — — — — — — — — — —
5NV-20 — — — — — — — 1 — — — — — — — — — — — — —
5NV-21 — — — — — — — — 8 — — — — — — — — — — — —
5NV-22 — — — — — — — — 7 — — — — — — — — — — — —
5NV-23 — — — — — — — — — 10 — — 13 — — 14 — — 10 — —
5NV-24 — — — — — — — — — 1 — — — — — — — — — — —
5NV-25 — — — — — — — — — 1 — — — — — — — — — — —
5NV-26 — — — — — — — — — 1 — — — — — — — — — — —
5NV-27 — — — — — — — — — 1 — — — — — — — — — — —
5NV-28 — — — — — — — — — 1 — — — — — — — — — — —
5NV-29 — — — — — — — — — — 12 — — — — — — — — — —
5NV-30 — — — — — — — — — — 1 — — — — — — — — — —
5NV-31 — — — — — — — — — — 1 — — — — — — — — — —
5NV-32 — — — — — — — — — — 1 — — — — — — — — — —
5NV-33 — — — — — — — — — — — 13 — — — — — — — — —
5NV-34 — — — — — — — — — — — 2 — — 15 — — — — — —
5NV-35 — — — — — — — — — — — — 1 — — — — — — — —
5NV-36 — — — — — — — — — — — — 1 — — — — — — — —
5NV-37 — — — — — — — — — — — — — 15 — — 14 — — 13 —
5NV-38 — — — — — — — — — — — — — — — 1 — — — — —
5NV-39 — — — — — — — — — — — — — — — — 1 — — — —
5NV-40 — — — — — — — — — — — — — — — — — 14 — — —
5NV-41 — — — — — — — — — — — — — — — — — 1 — — —
5NV-42 — — — — — — — — — — — — — — — — — — 3 — —
5NV-43 — — — — — — — — — — — — — — — — — — 1 — —
5NV-44 — — — — — — — — — — — — — — — — — — 1 — —
5NV-45 — — — — — — — — — — — — — — — — — — — 1 —
5NV-46 — — — — — — — — — — — — — — — — — — — 1 —
5NV-47 — — — — — — — — — — — — — — — — — — — — 14
5NV-48 — — — — — — — — — — — — — — — — — — — — 1
a Within passages, A, B, and C each represent one pig from which 15 plaque-cloned viruses were collected. —, no identical virus was found.
b CC-01 is the original virus inoculum in P1.
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notable exception to this trend was 5AV-01, which was de-
tected in line A at 7, 67, 127, 187, 247, 307, and 367 days of
passage. No variant “skipped” a passage(s), i.e., appeared,
went undetected in a subsequent passage(s), and appeared in a
later passage(s).
The ORF 5 sequences of CC-01, VR-2332, the RespPRRS
vaccine virus, and the 22 amino acid variants were aligned and
compared (Fig. 4). Among the 22 variants, no specific “hot
spots” were identified, except at position 151 (glycine to argi-
nine). Most amino acid substitutions due to nucleotide changes
were observed in amino acid residues located between residues
10 and 34. Eleven of the 22 5AVs had an amino acid substi-
tution at either residue 33 (asparagine to serine) or residue 34
(asparatic acid to asparagine or serine), which is part of the
ectodomain of GP5. An amino acid substitution at residue 33
abolished a postulated variable N-linked glycosylation site.
FIG. 4. GP5 amino acid sequence comparisons of CC-01, 22 amino acid variants, VR-2332, and the RespPRRS vaccine virus. Dots indicate
bases identical to those in CC-01, and letters indicate amino acid substitutions. Positions 41 to 90 and 101 to 120 have been truncated.
TABLE 4. Chronological appearance of 22 5AVs within three independent lines and over seven pig passages
Phenotype
No. of plaque-cloned viruses identical to each phenotype within the following passage and linea:
P1 P2 P3 P4 P5 P6 P7
A B C A B C A B C A B C A B C A B C A B C
CC-01b 5 14 7 — — — — — — — — — — — — — — — — — —
5AV-01 8 — 5 13 — 14 15 — — 14 — — 14 — — 15 — — 10 — —
5AV-02 1 — — — — — — — — — — — — — — — — — — — —
5AV-03 1 — 1 — — — — — — — — — — — — — — — — — —
5AV-04 — 1 1 — — — — — — — — — — — — — — — — — —
5AV-05 — — 1 — — — — — — — — — — — — — — — — — —
5AV-06 — — — 2 — — — — — — — — — — — — — — — — —
5AV-07 — — — — 9 1 — — — — — — — — — — — — — — —
5AV-08 — — — — 6 — — — — — — — — — — — — — — — —
5AV-09 — — — — — — — 14 — — 1 — — — — — — — — — —
5AV-10 — — — — — — — 1 — — — — — — — — — — — — —
5AV-11 — — — — — — — — 15 — — — — — — — — — — — —
5AV-12 — — — — — — — — — 1 — 2 — — 15 — — — — — —
5AV-13 — — — — — — — — — — 12 — — 15 — — 15 — — 13 —
5AV-14 — — — — — — — — — — 2 — — — — — — — — — —
5AV-15 — — — — — — — — — — — 13 — — — — — — — — —
5AV-16 — — — — — — — — — — — — 1 — — — — — — — —
5AV-17 — — — — — — — — — — — — — — — — — 15 — — —
5AV-18 — — — — — — — — — — — — — — — — — — 4 — —
5AV-19 — — — — — — — — — — — — — — — — — — 1 — —
5AV-20 — — — — — — — — — — — — — — — — — — — 1 —
5AV-21 — — — — — — — — — — — — — — — — — — — 1 —
5AV-22 — — — — — — — — — — — — — — — — — — — — 15
a See Table 3, footnote a.
b See Table 3, footnote b.
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Phylogenetic analysis (Fig. 5) revealed two distinct branches of
evolution among the 22 variants, with 8 of 9 variants from line
B on one branch and 13 of 14 variants from lines A and C on
the other branch.
(ii) Sequence analysis of PRRSV ORFs 1b and 7. ORF 1b
(polymerase domain) and ORF 7 (N protein) sequencing was
attempted with a total of 135 plaque-cloned viruses, i.e., 15
clones from each of three pigs in P1 (day 7 of in vivo replica-
tion), P2 (day 67 of in vivo replication), and P7 (day 367 of in
vivo replication). Partial sequences (435 bases) of ORF 1b
were obtained for 149 clones, including 15 clones from CC-01.
ORF 1b sequencing was not successful for one clone from line
A in P2. ORF 7 nucleotide sequences were obtained for all 135
plaque-cloned viruses.
Relative to CC-01, a total of 16 ORF 1b nucleotide variants
(1NVs) (Table 5) were observed, each containing from one to
four nucleotide changes. In P1, only one variant was detected
among 45 virus clones, but all 45 virus clones from P7 were
variants. All nucleotide changes were randomly distributed,
and only one ORF 1b amino acid variant (1AV) was found
(Table 6). Specifically, the mutation at position 207 (T to C) in
one virus clone recovered from line A in P7 resulted in an
amino acid substitution (valine to alanine). The remaining
nucleotide mutations were synonymous.
ORF 7 nucleotide sequencing revealed no changes in 107 of
the 135 pig-derived virus clones compared to CC-01. Nine
ORF 7 nucleotide variants (7NVs) were detected among the 28
remaining clones (Table 7), with each 7NV containing one or
two nucleotide changes at various positions. Analysis of the
sequences revealed that amino acid substitutions correspond-
ing to nucleotide mutations in 8 of the 28 clones resulted in
three ORF 7 amino acid variants (7AVs) (Table 8). Amino
acid substitutions in the three amino acid variants occurred at
residue 15 (asparagine to lysine), 128 (glutamine to arginine),
FIG. 5. Phylogenetic relationship of 22 PRRSV 5AVs detected during 367 days of in vivo replication. Letters in parentheses represent the lines
(A, B, and C) of pig passages in which the variant was recovered. Lines represent the distances of sequence divergence from the ancestor (CC-01).
TABLE 5. Appearance of 16 1NVs within three independent lines
and in three pig passages
Genotype
No. of plaque-cloned viruses identical to each genotype
within the following passage and linea:
P1 P2 P7
A B C Ab B C A B C
CC-01c 14 15 15 2 13 6 — — —
1NV-01 1 — — — — — — — —
1NV-02 — — — 9 — — — — —
1NV-03 — — — 1 — — — — —
1NV-04 — — — 2 — — — — —
1NV-05 — — — — 1 — — — —
1NV-06 — — — — 1 — — — —
1NV-07 — — — — — 6 — — —
1NV-08 — — — — — 1 — — —
1NV-09 — — — — — 2 — — —
1NV-10 — — — — — — 6 — —
1NV-11 — — — — — — 3 — —
1NV-12 — — — — — — 5 — —
1NV-13 — — — — — — 1 — —
1NV-14 — — — — — — — 14 —
1NV-15 — — — — — — — 1 —
1NV-16 — — — — — — — — 15
a See Table 3, footnote a.
b Sequencing was successful for 14 of the 15 clones.
c See Table 3, footnote b.
TABLE 6. Appearance of one 1AV within three independent lines
and in three pig passages
Phenotype
No. of plaque-cloned viruses identical to each phenotype
within the following passage and linea:
P1 P2 P7
A B C Ab B C A B C
CC-01c 15 15 15 14 15 15 14 15 15
1AV-01 — — — — — — 1 — —
a See Table 3, footnote a.
b Sequencing was successful for 14 of the 15 clones.
c See Table 3, footnote b.
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or 239 (lysine to arginine). The disappearance of 7AV-01 and
7AV-02 from subsequent passages suggests that these variants
underwent negative selection.
(iii) Collective sequence analysis. The genetic variation and
evolution of CC-01 during animal passages were further char-
acterized by combining the sequence data for ORFs 1b, 5, and
7. Among the 45 virus clones recovered from P1, 44 from P2,
and 45 from P7, a total of 40 combination nucleotide variants
(CNVs) and 19 combination amino acid variants (CAVs) were
identified (Tables 9 and 10). Thirteen CNVs and 9 CAVs were
detected among the 45 virus clones recovered at P7, i.e., after
a total of 367 days of in vivo replication. Most variants under-
went negative selection and disappeared from succeeding pas-
sages, but CAV-01 was detected in each line A pig in P1, P2,
and P7. Phylogenetic analysis (Fig. 6) showed that these CAVs
followed two distinct evolutionary directions. Similar to what
was observed for ORF 5, of the 19 CAVs, 5 of 6 variants from
line B were on one branch, while 12 of 13 variants from lines
A and C were on the other.
(iv) Rates and types of mutations. All sequences were com-
pared to the CC-01 sequence, and the mutation rates for ORFs
1b, 5, and 7 were calculated (Fig. 7). A very gradual increase in
nucleotide changes occurred in ORF 1b (435 bases) of PRRSV
over seven animal passages (Fig. 7, top). At the termination of
the study, the mean percentage of nucleotide changes among
45 plaque-cloned viruses of P7 was 0.67% compared to the
data for CC-01. However, most of the nucleotide changes were
synonymous mutations, i.e., no amino acid substitutions. The
ORF 7 gene (372 bases) of PRRSV was also conserved during
serial animal passages (Fig. 7, bottom). In comparison to the
data for CC-01, the mean percentages of changes among virus
clones were 0.01, 0.03, and 0.13% at the nucleotide level and
0.02, 0.02, and 0.11% at the amino acid level for P1, P2, and P7,
respectively.
The ORF 5 gene (603 bases) of PRRSV showed higher rates
of change during animal passages (Fig. 7, middle). The mean
percentages of changes in nucleotides were 0.09, 0.29, 0.53,
0.69, 0.61, 0.89, and 0.70% for P1 through P7, respectively.
Most of the nucleotide changes in ORF 5 were nonsynony-
mous mutations, resulting in substitutions of amino acid resi-
TABLE 7. Appearance of nine 7NVs within three independent
lines and in three pig passages
Genotype
No. of plaque-cloned viruses identical to each genotype
in the following passage and linea:
P1 P2 P7
A B C A B C A B C
CC-01b 15 15 13 13 14 13 9 15 —
7NV-01 — — 1 — — — — — —
7NV-02 — — 1 — — — — — —
7NV-03 — — — 1 — — — — —
7NV-04 — — — 1 — — — — —
7NV-05 — — — — 1 — — — —
7NV-06 — — — — — 1 — — —
7NV-07 — — — — — 1 — — —
7NV-08 — — — — — — 6 — —
7NV-09 — — — — — — — — 15
a See Table 3, footnote a.
b See Table 3, footnote b.
TABLE 8. Appearance of three 7AVs within three independent
lines and in three pig passages
Genotype
No. of plaque-cloned viruses identical to each genotype
in the following passage and linea:
P1 P2 P7
A B C A B C A B C
CC-01b 15 15 14 15 15 14 9 15 15
7AV-01 — — 1 — — — — — —
7AV-02 — — — — — 1 — — —
7AV-03 — — — — — — 6 — —
a See Table 3, footnote a.
b See Table 3, footnote b.
TABLE 9. Appearance of 40 CNVs within three independent lines
and in three pig passages
Genotype
No. of plaque-cloned viruses identical to each genotype
in the following passage and linea:
P1 P2 P7
A B C Ab B C A B C
CC-01c 5 12 6 — — — — — —
CNV-01 6 — 4 1 — 5 — — —
CNV-02 1 — — — — — — — —
CNV-03 1 — 1 — — — — — —
CNV-04 1 — — — — — — — —
CNV-05 1 — — — — — — — —
CNV-06 — 1 — — — — — — —
CNV-07 — 1 1 — — — — — —
CNV-08 — 1 — — — — — — —
CNV-09 — — 1 — — — — — —
CNV-10 — — 1 — — — — — —
CNV-11 — — 1 — — — — — —
CNV-12 — — — 8 — — — — —
CNV-13 — — — 1 — — — — —
CNV-14 — — — 1 — — — — —
CNV-15 — — — 1 — — — — —
CNV-16 — — — 1 — — — — —
CNV-17 — — — 1 — — — — —
CNV-18 — — — — 6 — — — —
CNV-19 — — — — 6 1 — — —
CNV-20 — — — — 1 — — — —
CNV-21 — — — — 1 — — — —
CNV-22 — — — — 1 — — — —
CNV-23 — — — — — 5 — — —
CNV-24 — — — — — 1 — — —
CNV-25 — — — — — 1 — — —
CNV-26 — — — — — 1 — — —
CNV-27 — — — — — 1 — — —
CNV-28 — — — — — — 4 — —
CNV-29 — — — — — — 1 — —
CNV-30 — — — — — — 3 — —
CNV-31 — — — — — — 1 — —
CNV-32 — — — — — — 1 — —
CNV-33 — — — — — — 1 — —
CNV-34 — — — — — — 4 — —
CNV-35 — — — — — — — 3 —
CNV-36 — — — — — — — 10 —
CNV-37 — — — — — — — 1 —
CNV-38 — — — — — — — 1 —
CNV-39 — — — — — — — — 14
CNV-40 — — — — — — — — 1
a See Table 3, footnote a.
b One clone was excluded from the analysis due to failure in sequencing ORF
1b.
c See Table 3, footnote b.
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dues. For deduced amino acids, rates of change in ORF 5 were
0.24, 0.77, 1.49, 1.32, 1.01, 1.67, and 1.24% for P1 through P7,
respectively.
The types of mutations occurring in ORFs 1b, 5, and 7
during animal passages are summarized in Tables 11 and 12.
Overall, transitions (G 171 A or T 171 C) were more common
than transversions (GA 171 TC). The numbers of transitions
per plaque-cloned virus during passage were consistent with
the mutation rates of the nucleotide sequences in the corre-
sponding genes, since transversions occurred only in a few
isolates. While ORFs 1b and 7 were relatively conserved dur-
ing serial animal passages, ORF 5 showed stable increases in
substitutions per clone from 0.58 to 3.87 for P1 through P7.
Assessment of antigenic changes. Five MAbs specific for the
N protein and two specific for the E protein were used to
detect changes in the epitopic profile of CC-01 during virus
evolution in animal passages. No abolition of reactivity with
FIG. 6. Phylogenetic relationship of 19 PRRSV CAVs. Letters (A, B, and C) represent the lines of pig passages in which the variant was
detected during 367 days of in vivo replication. Lines represent the distances of sequence divergence from the ancestor (CC-01).
FIG. 7. Mutation rates for PRRSV ORFs 1b, 5, and 7 over seven
animal passages (367 days of in vivo replication). The mutation rates
were calculated as the proportions of substitutions in each plaque-
cloned virus and are represented as the mean percent change on the
nucleotide (F) and amino acid (E) levels. Each symbol represents the
mean of mutation rates for 45 cloned isolates, except for 44 cloned
viruses in P2 for ORF 1b. Error bars are the standard errors of the
mean.
TABLE 10. Appearance of 19 CAVs within three independent lines
and in three pig passages
Phenotype
No. of plaque-cloned viruses identical to each phenotype
in the following passage and linea:
P1 P2 P7
A B C Ab B C A B C
CC-01c 6 14 7 — — — — — —
CAV-01 7 — 4 12 — 13 5 — —
CAV-02 1 — — — — — — — —
CAV-03 1 — 1 — — — — — —
CAV-04 — 1 1 — — — — — —
CAV-05 — — 1 — — — — — —
CAV-06 — — 1 — — — — — —
CAV-07 — — — 2 — — — — —
CAV-08 — — — — 6 — — — —
CAV-09 — — — — 9 — — — —
CAV-10 — — — — — 1 — — —
CAV-11 — — — — — 1 — — —
CAV-12 — — — — — — 4 — —
CAV-13 — — — — — — 1 — —
CAV-14 — — — — — — 4 — —
CAV-15 — — — — — — 1 — —
CAV-16 — — — — — — — 13 —
CAV-17 — — — — — — — 1 —
CAV-18 — — — — — — — 1 —
CAV-19 — — — — — — — — 15
a See Table 3, footnote a.
b One clone was excluded from the analysis due to failure in sequencing ORF 1b.
c See Table 3, footnote b.
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each of these MAbs was observed in any of each of the 45
plaque-cloned virus isolates collected from P1, P2, and P7,
demonstrating no correlation between observed amino acid
substitutions and epitopic changes. Likewise, a one-way VN
assay did not reveal the presence of plaque-cloned viruses
significantly resistant to the neutralizing activity of antisera
collected at day 60 p.i. in P1, suggesting that no escape mutant
was generated during seven animal passages under the condi-
tions of this experiment.
DISCUSSION
The purpose of this study was to describe the evolution of
PRRSV over time. Genetic and antigenic changes in a well-
characterized PRRSV isolate were documented during the
course of multiple pig passages over a period of 367 days under
experimental conditions.
Several strengths of the experimental design are worth not-
ing. First, a plaque-cloned virus inoculum, i.e., a uniform virus
population, rather than a whole virus isolate composed of
multiple variants (quasispecies) was used to initiate the infec-
tion in P1. This strategy provided a definitive ancestor against
which to compare and contrast descendant isolates. Second, in
P2 to P7, the use of tissue homogenates to pass virus directly
from pig to pig circumvented the selection pressures arising
from the in vitro isolation and propagation of viruses. Third,
the 60-day passage allowed the immune system to respond and
exert selective pressure on the virus population. Fourth, the
use of HEPA-filtered housing systems and adherence to strict
biosecurity procedures made it possible to maintain virus evo-
lution in three independent lines (replicates) of pig passages.
Fifth, the recovery of 15 plaque-cloned isolates directly from
serum made it possible to randomly sample the population of
PRRSV variants circulating in each pig and characterize their
distribution.
For the purposes of data interpretation, it should be recog-
nized that the sample size of 15 clones did not identify all the
unique nucleotide and protein sequences present. Specifically,
if the prevalence of a variant in the population of viruses
circulating in a pig exceeded 18%, the probability of recovering
at least one clone in the sample was greater than 0.95. As a
corollary, the proportion of any sequence among the 15 clones
was only an estimate of the prevalence in the pig. The exact
prevalence values should not be overinterpreted because there
is a moderate amount of uncertainty associated with these
estimates. For example, if a sequence was observed in 12 of the
15 clones (prevalence of 80%), the 95% confidence interval for
that prevalence estimate would be 52 to 95%.
Successful transmission of PRRSV via tissue samples col-
lected at 60 days p.i. provided additional evidence that PRRSV
infection persists in swine. However, it was observed that cell-
adapted virus behaved much differently in pigs than pig-
adapted virus. That is, inoculation of pigs in P1 with a cell-
adapted clone derived from ATCC VR-2332 produced a
pattern of viremia strikingly different, both in virus titer and in
duration of viremia, from that seen with such inoculation of
pigs in P2 to P7 (Fig. 3 and Table 2). These data are important
because they suggest that the results of experiments may differ
significantly depending on whether cell-adapted or pig-
adapted viruses are used. Although no genetic basis for this
biological difference was discovered, it is recommended that
future studies with direct application to the field use PRRSV
with a minimum amount of cell culture adaptation.
To date, no specific genetic markers have been linked to
either the attenuation or the virulence of PRRSV. However, it
is interesting to note the consistent substitution of a glycine
residue with arginine at position 151 of ORF 5 in all virus
clones after just one passage in pigs (Fig. 4). This change
represents a reversion to the amino acid residue of the parental
strain, VR-2332, a field isolate. Both PRRSV CC-01 and the
RespPRRS vaccine virus were derived from VR-2332 through
cell culture passage and, for the ORFs sequenced, shared
100% amino acid homology. Reversion of the amino acid res-
idue at position 151 of ORF 5 has been reported for the
RespPRRS vaccine virus and VR-2332 (2, 3, 40, 54, 59). Cu-
mulatively, these results lead us to speculate that the glycine
residue at position 151 of ORF 5 may be a marker for cell
TABLE 11. Mean number of nucleotide substitutions per plaque-cloned virus in ORF 5 (603 bases) of PRRSV over seven animal passages
Type
Mean (SEM) no. of nucleotide substitutions in the following passagea:
P1 P2 P3 P4 P5 P6 P7
Transition 0.58 (0.11) 1.69 (0.13) 3.24 (0.06) 3.91 (0.10) 3.38 (0.15) 4.73 (0.14) 3.87 (0.11)
Transversion 0 (0) 0.02 (0.02) 0 (0) 0 (0) 0.33 (0.07) 0.67 (0.07) 0.33 (0.33)
a A total of 45 plaque-cloned viruses were collected from each passage.
TABLE 12. Mean number of nucleotide substitution per plaque-cloned virus in ORF 1b (435 bases) and ORF 7 (372 bases) of PRRSV in
three animal passages
Type
Mean (SEM) no. of nucleotide substitutions in the following ORF and passagea:
ORF 1b ORF 7
P1 P2b P7 P1 P2 P7
Transition 0.02 (0.02) 0.57 (0.08) 2.58 (0.19) 0.33 (0.07) 0.59 (0.04) 0.47 (0.08)
Transversion 0 (0) 0 (0) 0.33 (0.07) 0.02 (0.02) 0.02 (0.02) 0 (0)
a A total of 45 plaque-cloned viruses were collected from each passage.
b A total of 44 plaque-cloned viruses were used in the assessment due to failure in sequencing 1 of the 45 clones.
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culture adaptation. Whether this specific change affects the
virulence or in vivo replication of PRRSV remains to be de-
termined.
Virus evolution in the three independent lines of pig pas-
sages was independent, i.e., highly random. Although numer-
ous genotypes were identified, with few exceptions, a single
variant was dominant in each pig at each passage. Unexpect-
edly, the dominant variant differed from one pig to the next,
even within the same line. The minor variants within a popu-
lation were often different from the dominant form by more
than one mutation. These observations suggested that a “pu-
rifying selection” may have occurred. This was especially true
for line C, where after seven passages and a total of 367 days
of in vivo replication, there was essentially only one kind of
virus, based on ORF 5. No evidence was obtained for radia-
tion, for an increase in diversity, or for the establishment of a
new, dominant mutation in the population. Rather, it appeared
that a single genotype gained a clear competitive advantage
and became the dominant form within a specific pig or passage.
The results of this study demonstrated that PRRSV evolves
continuously in infected pigs, with different genes of the viral
genome undergoing various degrees of change. As anticipated
for a housekeeping gene, PRRSV ORF 1b, which encodes the
RNA polymerase domain, was highly conserved. ORF 7 (N
protein) was also conserved during animal passages relative to
ORF 5 (E protein), suggesting that the internal structural
protein is genetically more stable than the external structural
proteins. This scenario may be due to the immune pressures to
which the external structural proteins are exposed. The rela-
tively low rates of mutation observed in ORFs 1b and 7 are
consistent with field observations (4, 18, 55).
Relative to ORFs 1b and 7, ORF 5 mutated at a much
higher rate; numerous genotypes (i.e., quasispecies) were iden-
tified, with mutiple genotypes being present concurrently in all
pigs. Based on an analysis of algorithms for hydrophobicity and
hydrophilicity and surface probability, six potential antigenic
sites were identified on the surface of GP5 of both North
American and European isolates (4, 45). Sequence analyses of
field isolates of PRRSV have revealed that variable regions are
located among amino acid residues near either the N terminus
(3 to 39) or the C terminus (164 to 200), whereas the most
conserved regions (II to IV) are located between amino acid
residues near 40 to 163 (4, 45). In agreement with previous
reports, our study found a high degree of amino acid substitu-
tions between residues 10 and 34, a region which contains the
signal peptide (1 to 31) and one variable N-linked glycosylation
site, whereas no or a few inconsistent changes were observed in
amino acid residues 40 through 160. Many ORF 5 variants had
amino acid substitutions at residue 33 (asparagine to arginine)
or 34 (aspartic acid to asparagine or arginine). Since amino
acids at positions 33 and 34 are known to be part of the
ectodomain of GP5, any change in this region may affect the
N-linked glycosylation or the conformation of GP5, which is
important for interactions with the M protein (19, 24, 29, 30,
32, 45, 44, 46, 53). Theoretically, such a change could result in
the loss of an epitope or an alteration in the immune response,
but no such changes were found in this study.
The appearance of ORF 5 quasispecies during in vivo rep-
lication suggests a potential role for mutation in viral persis-
tence. However, the overall mutation rate for ORF 5 was lower
than expected on the basis of the degree of diversity seen in
field isolates (24). The low rate of mutation in ORF 5 suggests
that ongoing mutation is not likely to be the mechanism by
which PRRSV eludes the immune system and persists in pigs.
It is believed that North American and European PRRSV
isolates were derived from a common lactate dehydrogenase-
elevating virus-like ancestor (40). Based on the relatively low
rate of mutation observed in this study and the 25 and 36%
amino acid divergences for ORFs 1b and 7 between strain
VR-2332 and the Lelystad virus (39, 40), we conclude that
these viruses diverged in the very distant past and experienced
independent evolutionary events. Given that the earliest evi-
dence places the introduction of PRRSV into domestic swine
in 1979 (8), the slow rate of mutation documented in this study
suggests that the extensive antigenic and genetic diversity ob-
served in PRRSV field isolates cannot be fully explained sim-
ply as a function of mutations. Alternate hypotheses to explain
the variability observed in field isolates would include recom-
bination, as shown among field isolates (24) or in vitro (65),
and possible ongoing evolution in alternate host species (67).
At present, the factors and conditions contributing to the di-
versity of PRRSV remain to be established.
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